KYMR
Price
$56.36
Change
-$1.19 (-2.07%)
Updated
Oct 7, 02:20 PM (EDT)
Capitalization
4.11B
23 days until earnings call
LQDA
Price
$23.95
Change
+$1.09 (+4.77%)
Updated
Oct 7, 02:37 PM (EDT)
Capitalization
1.97B
35 days until earnings call
Interact to see
Advertisement

KYMR vs LQDA

Header iconKYMR vs LQDA Comparison
Open Charts KYMR vs LQDABanner chart's image
Kymera Therapeutics
Price$56.36
Change-$1.19 (-2.07%)
Volume$475
Capitalization4.11B
Liquidia
Price$23.95
Change+$1.09 (+4.77%)
Volume$15.16K
Capitalization1.97B
KYMR vs LQDA Comparison Chart in %
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. LQDA commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a StrongBuy and LQDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 07, 2025
Stock price -- (KYMR: $57.55 vs. LQDA: $22.86)
Brand notoriety: KYMR and LQDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 57% vs. LQDA: 75%
Market capitalization -- KYMR: $4.11B vs. LQDA: $1.97B
KYMR [@Biotechnology] is valued at $4.11B. LQDA’s [@Biotechnology] market capitalization is $1.97B. The market cap for tickers in the [@Biotechnology] industry ranges from $103.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileLQDA’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • LQDA’s FA Score: 1 green, 4 red.
According to our system of comparison, LQDA is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 6 TA indicator(s) are bullish while LQDA’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 6 bullish, 4 bearish.
  • LQDA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than LQDA.

Price Growth

KYMR (@Biotechnology) experienced а -1.62% price change this week, while LQDA (@Biotechnology) price change was +0.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.87%. For the same industry, the average monthly price growth was +16.21%, and the average quarterly price growth was +89.49%.

Reported Earning Dates

KYMR is expected to report earnings on Oct 30, 2025.

LQDA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+7.87% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.12B) has a higher market cap than LQDA($1.97B). LQDA YTD gains are higher at: 94.388 vs. KYMR (43.052). LQDA has higher annual earnings (EBITDA): -133.4M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. LQDA (173M). KYMR has less debt than LQDA: KYMR (85.7M) vs LQDA (200M). KYMR has higher revenues than LQDA: KYMR (44.7M) vs LQDA (19.3M).
KYMRLQDAKYMR / LQDA
Capitalization4.12B1.97B209%
EBITDA-267.03M-133.4M200%
Gain YTD43.05294.38846%
P/E RatioN/AN/A-
Revenue44.7M19.3M232%
Total Cash665M173M384%
Total Debt85.7M200M43%
FUNDAMENTALS RATINGS
LQDA: Fundamental Ratings
LQDA
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
18
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRLQDA
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 7 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCLRX16.92N/A
N/A
BlackRock Advantage Large Cap Core Inv C
HOVLX55.67N/A
N/A
Homestead Value
TRHZX176.60N/A
N/A
T. Rowe Price Equity Index 500 Z
AMALX10.16N/A
N/A
American Century Small Cap Dividend G
DFDMX39.04-0.10
-0.26%
DF Dent Midcap Growth Investor